Procaps Group (NASDAQ:PROC – Get Free Report) and PureTech Health (NASDAQ:PRTC – Get Free Report) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their analyst recommendations, profitability, institutional ownership, dividends, earnings, valuation and risk. Analyst Recommendations This is a breakdown of […]
Procaps Group S.A. (NASDAQ:PROC – Get Free Report) was the target of a large increase in short interest in December. As of December 31st, there was short interest totalling 47,600 shares, an increase of 20.8% from the December 15th total of 39,400 shares. Based on an average daily trading volume, of 44,800 shares, the short-interest […]
Procaps Group (NASDAQ:PROC – Get Free Report) announced its quarterly earnings results on Tuesday. The company reported $0.05 earnings per share for the quarter, meeting analysts’ consensus estimates of $0.05, MarketWatch Earnings reports. The business had revenue of $118.41 million for the quarter, compared to the consensus estimate of $110.40 million. Procaps Group had a […]
Procaps Group (NASDAQ:PROC – Get Free Report) is set to announce its earnings results after the market closes on Tuesday, November 14th. Analysts expect the company to announce earnings of $0.05 per share for the quarter. Procaps Group (NASDAQ:PROC – Get Free Report) last announced its quarterly earnings results on Tuesday, September 5th. The company […]
Procaps Group S.A. (NASDAQ:PROC – Get Free Report) saw a large decline in short interest during the month of October. As of October 15th, there was short interest totalling 26,700 shares, a decline of 20.8% from the September 30th total of 33,700 shares. Currently, 0.1% of the shares of the company are sold short. Based […]